Immunohistochemical Analysis of the Expression of Breast Markers in Basal-like Breast Carcinomas Defined as Triple Negative Cancers Expressing Keratin 5

被引:10
|
作者
Zombori, Tamas [1 ]
Cserni, Gabor [1 ,2 ]
机构
[1] Univ Szeged, Dept Pathol, Fac Med, Allomas U 1, H-6725 Szeged, Hungary
[2] Bacs Kiskun Cty Teaching Hosp, Dept Pathol, Kecskemet, Hungary
关键词
Basal-like; Triple negative breast cancer; GATA-3; Mammaglobin; GCDFP-15; NY-BR-1; DISEASE FLUID PROTEIN-15; DIFFERENTIATION ANTIGEN NY-BR-1; UTEROGLOBIN GENE FAMILY; FEMALE GENITAL-TRACT; GATA3; IMMUNOHISTOCHEMISTRY; ESTROGEN-RECEPTOR; CLINICOPATHOLOGICAL ANALYSIS; MAMMAGLOBIN EXPRESSION; DIAGNOSTIC UTILITY; IDENTIFICATION;
D O I
10.1007/s12253-017-0246-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Estrogen and progesterone receptors are possible markers for suggesting a mammary origin of metastatic carcinoma, but are useless in cases of triple negative breast cancers (TNBC). Five other potential markers of breast origin were investigated on tissue microarrays in a series of TNBCs showing keratin 5 expression, consistent with a basal-like phenotype. GATA-3 staining was observed in 82 of 115 triple negative cases (71.3%) including 23 cases with > 5% staining. Mammaglobin staining was detected in 30 cases (26.0%) including 12 with > 5% staining. GCDFP-15 was seen in 23 cases (20.0%) including 9 with > 5% staining. NY-BR-1 positivity was present in 7 cases (6.0%) including 3 patients with > 5% staining. BCA-225 staining was observed in 74 cases (64.3%); however this latter marker lacks also specificity owing to the reported widespread staining in other malignancies. GATA-3, mammaglobin and GCDFP-15 coexpression was seen in one case (0.9%), whereas GATA-3 and mammaglobin or mammaglobin and GCDFP-15 coexpression was present in 2 and 2 cases (1.7%), respectively. Using at least 5% staining as cut-off, the expression of any of the last 4 markers was 34.7%. The expression of GATA-3, mammaglobin, GCDFP-15 and NY-BR-1 is lower in TNBC-s than in breast carcinomas in general, and this may be even lower in basal-like carcinomas. Although these markers are not fully specific, by using them, a subset of basal-like TNBC-s can be identified as of mammary origin. However, a substantial proportion will not show any staining with any of these markers.
引用
收藏
页码:259 / 267
页数:9
相关论文
共 50 条
  • [21] Triple Negative Breast Cancer: Outcome Correlation With Immunohistochemical Detection of Basal Markers
    Thike, Aye Aye
    Iqbal, Jabed
    Cheok, Poh Yian
    Chong, Angela Phek Yoon
    Tse, Gary Man-Kit
    Tan, Benita
    Tan, Patrick
    Wong, Nan Soon
    Tan, Puay Hoon
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2010, 34 (07) : 956 - 964
  • [22] Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistochemistry and transcriptional profiles
    Gazinska, Patrycja
    Grigoriadis, Anita
    Brown, John P.
    Millis, Rosemary R.
    Mera, Anca
    Gillett, Cheryl E.
    Holmberg, Lars H.
    Tutt, Andrew N.
    Pinder, Sarah E.
    MODERN PATHOLOGY, 2013, 26 (07) : 955 - 966
  • [23] Immunohistochemical characteristics of basal-like breast cancer
    Badowska-Kozakiewicz, Anna M.
    Budzik, Michal P.
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2016, 20 (06): : 436 - 443
  • [24] Metaplastic breast carcinomas are basal-like tumours
    Reis-Filho, J. S.
    Milanezi, F.
    Steele, D.
    Savage, K.
    Simpson, P. T.
    Nesland, J. M.
    Pereira, E. M.
    Lakhani, S. R.
    Schmitt, F. C.
    HISTOPATHOLOGY, 2006, 49 (01) : 10 - 21
  • [25] Dysregulation of the epigenome in triple-negative breast cancers: Basal-like and claudin-low breast cancers express aberrant DNA hypermethylation
    Roll, J. Devon
    Rivenbark, Ashley G.
    Sandhu, Rupninder
    Parker, Joel S.
    Jones, Wendell D.
    Carey, Lisa A.
    Livasy, Chad A.
    Coleman, William B.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2013, 95 (03) : 276 - 287
  • [26] Triple-negative/basal-like breast cancer: clinical, pathologic and molecular features
    Venkitaraman, Ramachandran
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (02) : 199 - 207
  • [27] p16 expression correlates with basal-like triple-negative breast carcinoma
    Abou-Bakr, Amany A.
    Eldweny, Hany I.
    ECANCERMEDICALSCIENCE, 2013, 7
  • [28] Triple-negative breast cancer and basal-like subtype : Pathology and targeted therapy
    Bando, Yoshimi
    Kobayashi, Tomoko
    Miyakami, Yuko
    Sumida, Satoshi
    Kakimoto, Takumi
    Saijo, Yasuyo
    Uehara, Hisanori
    JOURNAL OF MEDICAL INVESTIGATION, 2021, 68 (3-4): : 213 - 219
  • [29] Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers
    De Brot, Marina
    Rocha, Rafael M.
    Soares, Fernando A.
    Gobbi, Helene
    PATHOLOGY, 2012, 44 (04) : 303 - 312
  • [30] Characterizing basal-like triple negative breast cancer using gene expression analysis: A data mining approach
    Zadeh, Amir Hassan
    Alsabi, Qamar
    Ramirez-Vick, Jaime E.
    Nosoudi, Nasim
    EXPERT SYSTEMS WITH APPLICATIONS, 2020, 148